Teligent, Inc. (TLGT)

$0.1735

-0.03 (-13.85%)
Rating:
Recommendation:
Neutral
Symbol TLGT
Price $0.1735
Beta 1.618
Volume Avg. 7.97M
Market Cap 16.104M
Shares () -
52 Week Range 0.02-1.6
1y Target Est -
DCF Unlevered TLGT DCF ->
DCF Levered TLGT LDCF ->
ROE 17.42% Buy
ROA -12.37% Sell
Operating Margin -
Debt / Equity -253.55% Sell
P/E -
P/B -0.28 Neutral
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest TLGT news


Mr. Timothy Sawyer
Healthcare
Drug Manufacturers—Specialty & Generic
Nasdaq Global Select

Teligent, Inc., formerly Igi Laboratories Inc, is a specialty generic pharmaceutical company. Under the Company's own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 35 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2018. It provides development, formulation and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic industries. It focuses on developing, manufacturing and marketing a portfolio of generic pharmaceutical products under its own label in topical, injectable, complex and ophthalmic dosage forms, and managing its contract manufacturing and formulation services business. Its pipeline included 20 Abbreviated New Drug Application (ANDAs) filed with the United States Food and Drug Administration (FDA) for additional pharmaceutical products, as of December 31, 2018.